Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Complex regional pain syndrome type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Complex regional pain syndrome type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Complex regional pain syndrome type 1 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Read →
Gorham disease bone loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Gorham disease bone loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Gorham disease bone loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Juvenile Paget disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Juvenile Paget disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Juvenile Paget disease strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Paget disease of bone Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Paget disease of bone Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Paget disease of bone strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Osteitis fibrosa cystica Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Osteitis fibrosa cystica Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Osteitis fibrosa cystica strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Renal osteodystrophy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Renal osteodystrophy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Renal osteodystrophy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Vitamin D-dependent rickets type 2B Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Vitamin D-dependent rickets type 2B Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vitamin D-dependent rickets type 2B strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Read →
Autosomal dominant hypophosphatemic rickets Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Autosomal dominant hypophosphatemic rickets Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Autosomal dominant hypophosphatemic rickets strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Read →
Vitamin D-dependent rickets type 2A Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Vitamin D-dependent rickets type 2A Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vitamin D-dependent rickets type 2A strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Read →
Vitamin D-dependent rickets type 1B Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Vitamin D-dependent rickets type 1B Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vitamin D-dependent rickets type 1B strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Read →
Vitamin D-dependent rickets type 1A Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Vitamin D-dependent rickets type 1A Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vitamin D-dependent rickets type 1A strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Read →
Autosomal recessive hypophosphatemic rickets Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Autosomal recessive hypophosphatemic rickets Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Autosomal recessive hypophosphatemic rickets strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Read →